NovaBay Pharmaceuticals effects 1-for-5 reverse stock split

Stablecoin Development Corp

Reverse stock split effective at 4:15 p.m. ET on Feb 20, 2026; trading on split-adjusted basis from Feb 23.
Ratio 1-for-5; no fractional shares issued (additional whole share provided for fractions).
Authorized shares unchanged at 1.5 billion; par value remains $0.01 per share.
Trading symbol unchanged as 'NBY'; new CUSIP number 66987P508.
Stockholder approval obtained Oct 16, 2025; Board approved ratio on Feb 11, 2026.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Stablecoin Development Corp: Amended certificate of incorporation to effect a 1-for-5 reverse stock split (effective 2026-02-20).

Change: charter amendment
Effective: 2026-02-20

Exact text from the filing

On February 20, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) filed a certificate of amendment (“Certificate of Amendment”) providing for an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (“Certificate of Incorporation”), to effect a reverse stock split at a ratio of 1-for-5 (the “Reverse Stock Split”).

View on SEC.gov

40 governance changes filed in the last 30 days. Browse all governance changes →

Stablecoin Development Corp filing history →

Source: SEC EDGAR

accession 0001437749-26-004922

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.